CSE ticker: GW 2 VALENS GROWORKS NOTICE TO RECIPIENT This - PowerPoint PPT Presentation

Investor Presentation January 2019 CSE ticker: GW

2 VALENS GROWORKS NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete investment program, who do not require immediate liquidity for their investment and who fully understand and are willing to assume the risks involved. An investment may be considered to involve a substantial degree of risk, and an investor could lose all or a substantial amount of his or her investment. This document is not an offer to sell (or solicitation of an offer to buy) any interest in the Company. These materials may not be used or relied upon for any purpose other than as specifically contemplated by a written agreement. The materials may not be circulated outside of the recipient’s organization, publicly referred to, or disclosed, i n whole or in part, without express written permission. This presentation does not purport to be all inclusive or contain all the information that a prospective investor may require to fully evaluate an investment in the contemplated transaction. Prospective investors should conduct their own thorough investigation and due diligence before making an investment. DISCLAIMER This Presentation contains forward-looking statements and forward-looking information. Often, but not always, forward-looking statements can be identified by the use of words or phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward -looking statements involve known and unknown words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and risks, uncerta inties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and information. Examples of such statements include: (A) the financial forecast of the Company; (B) the intention to grow the business and operations of the Company; (C) anticipated timing for the av ailability of the Company’s products to market and expected sale prices; (D) expected growth in the number of users of medical and recreational marijuana anticipated; and (E) the expansion of the Company’s busin ess into other revenue streams. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this Presentation. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability of the Company to obtain necessary financing; the ability to complete a going public transaction; the ability to satisfy the requirements of a stock exchange; the economy generally; consumer interest in the products of the Company; competition; and anticipated and unanticipated costs. These forward- looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this Presentation. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements and information contained in this Presentation are expressly qualified in their entirety by this cautionary statement. The forward-looking statements and information included in this Presentation are made as of the date of this Presentation and the Company assumes no obligation to update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation. CSE ticker: VGW

and the first colab facilitating cannabis product development for licensed producers globally One of the largest premium cannabis extraction companies in North America 3 VALENS GROWORKS

lost in the refining process. Different strains, compounds and growing techniques preferred partner of Canopy and other reputable industry players. PRODUCT FLEXIBILITY We have the ability to produce a wide variety of products, allowing Valens to capitalize on multiple markets from medical to recreational to preferential method of consumption. SEED TO SALE TRANSPARENCY AND CONTROL provide different desired effects in finished products. The experience and reputation of the By controlling our supply from the source right through to processing, we’re able to ensure our products qualities are maximized and always purpose-driven. PROPRIETARY PROCESSING Our processing methods have been customized to ensure that the end product does not lose the valuable complexity of compounds responsible for the spectrum of desired effects that are often team at Valens speaks for itself. We are a INDUSTRY-BACKED perform research and clinical trials products and services in the market . pending, Hemp License pending, Nutraceutical License pending – setting Valens up for every servicing and consumer product opportunity, globally. DEVELOPMENT Through one of our Dealer’s Licenses we hold the ability to to better understand Cannabis and it’s benefits, and to lead the way in purposeful product offerings around the world. BIG PICTURE BRANDING The Valens brand is recognized for delivering the most science driven, responsibly tested, sustainably derived Health Canada licensed (multiple), EU GMP certification THE VALENS ADVANTAGE 4 VALENS GROWORKS THE WORLD IS OUR MARKET

Third party cannabis product development EU GMP Certification pending for global export anywhere Extraction center with cultivation and research capabilities 25,000 sq ft plant to facilitate additional extraction production Proprietary, customized cannabis extraction processes One of the largest capacities to extract in Canada and growing Ability to import and export wholesale cannabis products world-wide Health Canada licensed cannabis extraction center VALENS AGRITECH LTD. VALENS GROWORKS • • • • • • •

pesticides, mold, terpenes and cannabinoid profile Health Canada licensed cannabis extraction center ISO 17025 accreditation, first lab to be accredited in Canada for a cannabis matrix medical instruments company Thermo Fischer Scientific product verification as well as globally. VALENS LABS LTD. VALENS GROWORKS • Health Canada Dealers Licensed for testing and analysis • Leading edge research laboratory • Service provider specializing in the testing of metals, residual solvents, • • Named a “Center of Excellence in Plant Based Science” by $115B • Setting the domestic standard in Health Canada-required third party

OTHER REVENUE SOURCES Direct Sales Export Sales Revenue share Revenue share or Fee for service Fee for service of oil for market Processing and packaging oil ready for market Processing from flower to flower to crude oil Processing from 3rd Party Research & Development Product Development ABILITY TO CREATE CUSTOM, FLEXIBLE AGREEMENTS Lab Testing Services VALENS REVENUE STREAMS 7 VALENS GROWORKS EXTRACTION EXTRACTION W HITE LABEL W HITE LABEL RESIN RESIN REFINED OIL REFINED OIL PRODUCTS PRODUCTS • • • • •

Vaporizer Cartridges and Pens with the powder dispenser on top TOPICALS EDIBLES Balms/creams/salves High THC/CBD tinctures Bath soaks/salts OIL/TINCTURES Oral sprays Skin care products Drinks – alcoholic or non-alcoholic Body sprays Lubricants Concentrates vitamin waters cannabis oil preloaded in the top, just like the “Just add cannabis” – beverage containers with Essential oils Food additives – Cooking oils, honey, peanut butter Sublingual patches Infused prepared meals Transdermal patches etc. Snack edibles – Trail mix, protein bars, jerky, sweets, Capsules EXTRACTION: THE FOUNDATION OF OPPORTUNITY 8 VALENS GROWORKS • • • • • • • • • • • • • • • • • • •

Value-add in our oil services process to provide clients with water-soluble cannabis ready for mixing in All of this means you can add cannabis to products including beverages without that "weed" taste or smell . BREAKTHROUGH ITEMS TO NOTE Shelf stable for over 180 days (not proven anywhere else) Washington, three years in a row, Happy Apple Cider. Zero cannabis taste, color or odor Exclusive Canadian rights to all Tarukino beverages including the #1 selling cannabis beverage in Provides effective, consistent dosing Powder product ready to go to market that consumers can mix with any liquid of their own Lower dosage sufficient due to increase in bioavailability when consumed liquids by the client Faster onset and offset, making it the safer and more trusted edible option WHAT THIS MEANS FOR VALENS 9 SoRSE TECHNOLOGY VALENS GROWORKS S ō RSE emulsion technology surrounds oils, transforming the entire solution into water-compatible forms • • • • • • • •